Business Context and Reporting Period
Company: Grupo Aval Acciones Y Valores S.A.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Reporting Period: Year 2023 (Report Date: January 31, 2024; Filing Date: February 1, 2024)
Subject: Implementation of Best Corporate Practices Report pursuant to the Colombian Code for Best Corporate Practices.
This filing details the company's compliance with corporate governance recommendations regarding shareholder rights, Board of Directors structure, control architecture, and transparency. It is not a financial results report.
Key Financial Metrics
Revenue, Profit, Cash Flow, Margins, Debt, Liquidity: The filing text does not provide specific financial values, ratios, or performance metrics for the 2023 period. This document focuses exclusively on governance compliance.
Board Composition (as of Dec 31, 2023): The Board consists of 7 members, including 2 independent directors (approximately 28%).
Material Changes and Governance Updates
- Board Committees: The company has established an Audit Committee, a Risk Committee (created June 9, 2021), and a Corporate Governance Committee (created August 26, 2020).
- Independent Directors: As of December 31, 2023, the Board includes 2 independent members out of 7 total members.
- Internal Audit Independence: The company notes that the Internal Audit Management functionally depends on the Presidency of the Corporation rather than exclusively on the Audit Committee, though it maintains professional independence from Senior Management.
- Statutory Auditor Rotation: The company implements a rotation of individuals occupying the position of Statutory Auditor every five years but has not foreseen a mandatory rotation term for the auditing firm itself.
Guidance, Outlook, and Risks
Management Commentary: Management emphasizes a "three lines of defense" risk management model and adherence to the COSO 2013 framework for internal control. The company maintains an Ethical Hotline for anonymous reporting of illegal or unethical behaviors.
Risks and Contingencies:
- Non-Implementation of Specific Recommendations: The company has identified several recommendations it has not fully adopted or plans to consider in subsequent periods, including:
- Alternating internal evaluation techniques with external evaluations by independent advisors for the Board (Measure 19.10).
- Full implementation of the Nomination and Compensation Committee's role in assessing senior management candidates (Measure 24.3).
- Annual performance assessment of the President led by the Nomination and Compensation Committee (Measure 24.5).
- Compensation policy for the President and Senior Management bound to long-term objectives and risk levels (Measure 24.6).
- Mandatory turnover of the auditing firm halfway through the maximum contract term (Measure 29.10).
- Legal Constraints: Certain recommendations were marked "N/A" due to legal reasons, such as the inability to publish a complement to a meeting call once the original call has been legally executed (Measure 10.9).
Important Facts for Investor Verification
- Financial Data Absence: Verify actual 2023 financial performance (revenue, net income, liquidity) in the company's Form 20-F or quarterly reports, as this 6-K contains no financial figures.
- Board Independence: Confirm the current percentage of independent directors (reported as ~28% as of Dec 31, 2023) against the company's own governance targets and regulatory minimums.
- Internal Audit Structure: Note the functional dependency of Internal Audit on the Presidency rather than the Audit Committee, which differs from some international best practices.
- Compensation Policies: Review the specific compensation policies for Senior Management, as the company indicated it has not yet fully implemented recommendations regarding variable compensation linked to long-term objectives and risk levels.
- Auditor Rotation: Verify the specific terms of the Statutory Auditor contract regarding firm rotation, as the company does not currently mandate firm turnover halfway through the contract term.